FEB 25, 2016 9:05 AM PST

Ordinary Skin Cells Transformed Into Brain Tumor Assassinators

WRITTEN BY: Xuan Pham
Reprogrammed stem cells (green) hunt and kill glioblastoma cells (pink)Cellular reprogramming has been a hot topic in translational and regenerative medicine ever since it was first described almost a decade ago. Recently, a team from the University of North Carolina (UNC) Chapel Hill harnessed this potential, turning ordinary skin cells into predators that kill brain cancer cells. This innovation is hailed as a breakthrough in medical science, as it provides the potential of a new treatment option for an intractable form of brain cancer known as glioblastoma.
 
Glioblastoma (GBM) is the most common and deadly form of primary brain cancer. In GBM, malignant glial cells form vast networks of tendrils throughout the brain, making it nearly impossible to surgically remove all the cancerous tissues. Dubbed as the “octopus tumor,” GBMs can evade even the most aggressive surgeries, chemotherapies, and radiotherapies, leaving patients with a five-year survival rate of less than 10%.
 
"Patients desperately need a better standard of care," said Shawn Hingtgen, senior study author and assistant professor in the UNC Eshelman School of Pharmacy.
 
To combat hidden GBM tumor cells, the research team turned to neural stem cells (NSCs), which have an innate ability to move throughout the brain, accessing hard-to-reach solid and invasive cancer cells. But the limited supply of NSCs deep within the adult brain is not enough to fight GBM. So researchers at UNC decided to make more of these NSCs.
 
 
Starting with fibroblasts, which are ordinary skin cells that produce collagen and connective tissues, the researchers added reprogramming factors and coaxed these cells to become induced neural stem cells (iNSCs). When transplanted into mice, these iNSCs had the ability to move throughout the brain, along with the penchant for killing brain tumor cells. In mice with different tumor types, the iNSCs increased survival time by 160 to 220 percent.
 
The researchers are exploring genetic modifications that would enable the iNSCs to release toxic tumor-killing proteins. Additionally, the iNSCs can be adapted to carry anti-cancer drugs, which would then be ferried directly to the cancer cells, killing cancer at its home base. Both types of modifications would make the iNSCs an even more aggressive assassinator of cancer cells in the brain.
 
"Our work represents the newest evolution of the stem-cell technology that won the Nobel Prize in 2012," Hingtgen said. "We wanted to find out if these induced neural stem cells would home in on cancer cells and whether they could be used to deliver a therapeutic agent. This is the first time this direct reprogramming technology has been used to treat cancer."

Additional source: EurekAlert!
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
AUG 10, 2020
Cancer
A New Prognostic Biomarker for Paclitaxel Sensitivity in Breast Cancer
AUG 10, 2020
A New Prognostic Biomarker for Paclitaxel Sensitivity in Breast Cancer
Breast cancer is one of the deadliest cancers globally. It has been studied extensively with plenty of treatments availa ...
AUG 15, 2020
Cardiology
Following Platelets to Diagnose Myocarditis
AUG 15, 2020
Following Platelets to Diagnose Myocarditis
The heart is a sensitive thing, prone not just to metaphorical heartbreak, but genuine issues if not taken care of. Myoc ...
AUG 20, 2020
Clinical & Molecular DX
Machines Learn the Difference Between Autism and Schizophrenia
AUG 20, 2020
Machines Learn the Difference Between Autism and Schizophrenia
 
SEP 02, 2020
Clinical & Molecular DX
Feeling Tired? Scientists Use Brain Scans to Measure Fatigue
SEP 02, 2020
Feeling Tired? Scientists Use Brain Scans to Measure Fatigue
Yawning in the middle of the day is completely normal for people with hectic schedules. How do you know whether it&rsquo ...
SEP 15, 2020
Cell & Molecular Biology
Autism Spectrum Disorder Biomarker is Discovered
SEP 15, 2020
Autism Spectrum Disorder Biomarker is Discovered
Scientists may have identified a biomarker for autism spectrum disorder, which can be difficult to differentiate from ot ...
SEP 17, 2020
Clinical & Molecular DX
Blood Vessels on a Chip Test Clotting
SEP 17, 2020
Blood Vessels on a Chip Test Clotting
Blood clotting, also known as coagulation, is a critical biological mechanism to prevent excessive blood loss in the eve ...
Loading Comments...